Skip to main content

Treatment Guidelines Materials

Treatment Guidelines Materials

Civil Society Perspectives on TB Policy in Thailand

This report highlights the work of community-based organizations and people living with HIV/AIDS in advocating for coordinated TB and HIV policies and services in their countries. The report presents case studies that highlight community advocates’ strategies, achievements, and lessons learned.

Política De TB No Brasil[Civil Society Perspectives on TB Policy in Brazil]

This report highlights the work of community-based organizations and people living with HIV/AIDS in advocating for coordinated TB and HIV policies and services in their countries. The report presents case studies that highlight community advocates’ strategies, achievements, and lessons learned.

Tuberculosis Infection Control in the Era of Expanding HIV Care and Treatment

Addendum to WHO "Guidelines for the Prevention of Tuberculosis in Health Care Facilities in Resource-Limited Settings, 1999"
The goal of this addendum is to help management and staff minimize the risk of TB transmission at facilities in resource-limited settings in which HIV-infected persons receive diagnosis, care, treatment, and/or support, and settings in which there is a high prevalence of HIV infection, both known and undiagnosed.

Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States. Morbidity and Mortality Weekly Report 54(RR15): 49-55, December 16, 2005

These CDC guidelines provide recommendations for using and interpreting the QuantiFERON-TB test in the detection of TB infection.

Engaging All Health Care Providers in TB Control: Guidance on Implementing Public-Private Mix Approaches

This document guides NTPs on how to engage all relevant health care providers in TB control and thereby promote the use of evidence-based, International Standards for TB Care. The experience and evidence on scaling up and sustaining PPM is now clearly emerging. The authors hope that this document will help countries to scale up PPM DOTS more rapidly and contribute significantly to achieving the TB-related Millennium Development Goal.

Priorities for Tuberculosis Bacteriology Services in Low Income Countries

This is the second edition of the "Red Book". It provides guidance to national tuberculosis programmes and the laboratory network on the role of TB laboratory services. It outlines the main responsibilities within the network and the technical and organisational aspects of microscopic sputum-smear examination and the surveillance of anti-tuberculosis drug resistance. The purpose of this monograph is to complement other texts on mycobacteriology and thus it is limited in its scope and emphasis.

TB CARE I Tools

This website contains general information about TB, TB guidelines, and country specific documents that are found on TB CAP's Toolbox CD ROM.

CDC Immigration Requirements: Technical Instructions for Tuberculosis Screening and Treatment

A document on technical instructions for TB screening and treatment for panel physicians on persons overseas applying for U.S immigration status and non-immigrants who are required to have an overseas medical examination.

Policy Guidelines for Collaborative TB and HIV Services for Injecting and Other Drug Users: An Integrated Approach

The Policy Guidelines outline the detailed evidence and explanation of the recommendations and describe the methods, the people involved and the summary of conflicts of interest. The aim of this guidance is to provide a strategic
approach to reducing TB- and HIV-related morbidity and mortality among drug users and their communities in a way that promotes holistic and person-centred services.

Clinical Policies and Protocols

This manual describes policies, protocols and recommendations for the prevention, treatment and control of tuberculosis from the New York City Department of Health and Mental Hygiene (NYC DOHMH). The protocols address testing, preventive treatment, initial evaluation for TB, treatment of TB disease and drug-resistant TB, monitoring and follow-up evaluation, infection control, and case management.